Literature DB >> 11583979

Exclusive neutrophil recruitment with oncostatin M in a human system.

S M Kerfoot1, E Raharjo, M Ho, J Kaur, S Serirom, D M McCafferty, A R Burns, K D Patel, P Kubes.   

Abstract

Oncostatin M (OSM), a member of the IL-6 family has been postulated to be a potent recruiter of leukocytes, however information regarding the molecular mechanism(s) underlying this event is extremely limited. Therefore, the aim of this study was to investigate the role of OSM-mediated leukocyte recruitment in a human system in vitro under flow conditions. A parallel-plate flow chamber assay was used to examine leukocyte recruitment from whole blood by human umbilical vein endothelium treated for 24 hours with OSM. OSM in a dose-response manner revealed very significant leukocyte rolling and adhesion reaching optimal levels at a very low concentration of OSM (10 ng/ml). The OSM-induced leukocyte rolling and adhesion was comparable to levels seen with tumor necrosis factor. OSM was extremely selective for neutrophil recruitment (96%) with <3% lymphocyte recruitment. By contrast, tumor necrosis factor-alpha revealed no such selectivity, recruiting 70% neutrophils and at least 25% lymphocytes and detectable levels of eosinophils at 24 hours. The molecular mechanism underlying the leukocyte recruitment seemed to be entirely dependent on P-selectin as leukocyte recruitment could be completely blocked by the addition of a P-selectin-blocking antibody. An elevation in both P-selectin message and protein was observed with 24 hours of OSM stimulation of endothelium. By contrast, E-selectin and VCAM-1 were not detectable after OSM stimulation. Similar results were seen with passaged dermal microvascular endothelium that does not have a prestored pool of P-selectin. Based on these results, we conclude that OSM may be a very selective potent recruiter of neutrophils in more prolonged inflammatory conditions, an event exclusively dependent on P-selectin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583979      PMCID: PMC1850489          DOI: 10.1016/S0002-9440(10)62538-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Adhesion and signaling in vascular cell--cell interactions.

Authors:  G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Divergent inducible expression of P-selectin and E-selectin in mice and primates.

Authors:  L Yao; H Setiadi; L Xia; Z Laszik; F B Taylor; R P McEver
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

Review 4.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Absence of P-selectin delays fatty streak formation in mice.

Authors:  R C Johnson; S M Chapman; Z M Dong; J M Ordovas; T N Mayadas; J Herz; R O Hynes; E J Schaefer; D D Wagner
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Multistep navigation and the combinatorial control of leukocyte chemotaxis.

Authors:  E F Foxman; J J Campbell; E C Butcher
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

7.  Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion.

Authors:  L Ostrovsky; R C Woodman; D Payne; D Teoh; P Kubes
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

8.  Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3.

Authors:  Y Khew-Goodall; C M Butcher; M S Litwin; S Newlands; E I Korpelainen; L M Noack; M C Berndt; A F Lopez; J R Gamble; M A Vadas
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

9.  Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells.

Authors:  L Yao; J Pan; H Setiadi; K D Patel; R P McEver
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  The association between alpha4-integrin, P-selectin, and E-selectin in an allergic model of inflammation.

Authors:  S Kanwar; D C Bullard; M J Hickey; C W Smith; A L Beaudet; B A Wolitzky; P Kubes
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  17 in total

1.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

2.  Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis.

Authors:  Hendra Setiadi; Tadayuki Yago; Zhenghui Liu; Rodger P McEver
Journal:  Blood Adv       Date:  2019-01-22

Review 3.  Neutrophil plasticity in the tumor microenvironment.

Authors:  Morgan A Giese; Laurel E Hind; Anna Huttenlocher
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

4.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

5.  Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow.

Authors:  Supattra Serirom; Wahaju H Raharjo; Kesinee Chotivanich; Sornchai Loareesuwan; Paul Kubes; May Ho
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.

Authors:  Doryssa Hermans; Evelien Houben; Niels Hellings; Bieke Broux; Paulien Baeten; Helena Slaets; Kris Janssens; Cindy Hoeks; Baharak Hosseinkhani; Gayel Duran; Seppe Bormans; Elizabeth Gowing; Chloé Hoornaert; Lien Beckers; Wing Ka Fung; Horst Schroten; Hiroshi Ishikawa; Judith Fraussen; Ronald Thoelen; Helga E de Vries; Gijs Kooij; Stephanie Zandee; Alexandre Prat
Journal:  Acta Neuropathol       Date:  2022-06-06       Impact factor: 15.887

Review 7.  Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression.

Authors:  Zimam Mahmud; Atiqur Rahman; Israt Dilruba Mishu; Yearul Kabir
Journal:  Cancer Metastasis Rev       Date:  2022-03-21       Impact factor: 9.237

8.  Potential of oncostatin M to accelerate diabetic wound healing.

Authors:  Soo Hye Shin; Seung-Kyu Han; Seong-Ho Jeong; Woo-Kyung Kim
Journal:  Int Wound J       Date:  2012-11-01       Impact factor: 3.315

Review 9.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

10.  TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.

Authors:  Tao Chen; Zai-pei Guo; Li Li; Meng-meng Li; Ting-ting Wang; Rui-zhen Jia; Na Cao; Jing-yi Li
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.